A detailed history of Oarsman Capital, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Oarsman Capital, Inc. holds 34,528 shares of PFE stock, worth $922,242. This represents 0.19% of its overall portfolio holdings.

Number of Shares
34,528
Previous 34,232 0.86%
Holding current value
$922,242
Previous $957,000 4.39%
% of portfolio
0.19%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $8,199 - $9,291
296 Added 0.86%
34,528 $999,000
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $3,031 - $3,552
120 Added 0.35%
34,232 $957,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $532,479 - $611,456
20,567 Added 151.84%
34,112 $946,000
Q4 2023

Feb 16, 2024

SELL
$26.13 - $33.94 $25,241 - $32,786
-966 Reduced 6.66%
13,545 $389,000
Q3 2023

Oct 27, 2023

BUY
$32.09 - $37.51 $69,635 - $81,396
2,170 Added 17.58%
14,511 $481,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $36,156 - $41,831
-1,001 Reduced 7.5%
12,341 $452,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $13,431 - $17,486
-341 Reduced 2.49%
13,342 $544,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $80,368 - $104,912
-1,925 Reduced 12.33%
13,683 $701,000
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $52,862 - $64,531
1,208 Added 8.39%
15,608 $683,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $113,812 - $134,945
-2,446 Reduced 14.52%
14,400 $755,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $220,011 - $272,622
-4,809 Reduced 22.21%
16,846 $872,000
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $110,696 - $164,088
-2,679 Reduced 11.01%
21,655 $1.28 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $77,950 - $100,134
-1,986 Reduced 7.55%
24,334 $1.05 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $8,402 - $9,519
234 Added 0.9%
26,320 $1.03 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $102,713 - $115,840
-3,067 Reduced 10.52%
26,086 $945,000
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $15,530 - $19,747
-464 Reduced 1.57%
29,153 $1.07 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $6,889 - $8,083
-217 Reduced 0.73%
29,617 $1.09 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $154,756 - $187,742
5,138 Added 20.8%
29,834 $976,000
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $152,638 - $218,087
-5,647 Reduced 18.61%
24,696 $806,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $4,773 - $5,417
145 Added 0.48%
30,343 $1.19 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $2,794 - $3,623
-86 Reduced 0.28%
30,198 $1.09 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1,996 - $2,242
-54 Reduced 0.18%
30,284 $1.31 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $25,200 - $27,686
-672 Reduced 2.17%
30,338 $1.29 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $48,626 - $55,439
-1,264 Reduced 3.92%
31,010 $1.35 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $22,577 - $27,385
-655 Reduced 1.99%
32,274 $1.42 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $46,996 - $50,102
-1,425 Reduced 4.15%
32,929 $1.2 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $48,279 - $56,011
-1,513 Reduced 4.22%
34,354 $1.22 Million
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $63,692 - $67,580
-1,915 Reduced 5.07%
35,867 $1.3 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.17 Million - $1.29 Million
37,782
37,782 $1.35 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Oarsman Capital, Inc. Portfolio

Follow Oarsman Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.